Half-year report · Q2

Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥14.7bn2024-01-01 → 2024-06-30Cons.Net sales
Revenue¥20.5bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥10.7bn2023-01-01 → 2023-06-30Cons.Net sales
Operating income¥2.3bn2024-01-01 → 2024-06-30Cons.Operating income
Operating income¥2.4bn2023-01-01 → 2023-06-30Cons.Operating income
Ordinary income¥3.2bn2024-01-01 → 2024-06-30Cons.Ordinary income
Ordinary income¥3.8bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.8bn2023-01-01 → 2023-06-30Cons.Ordinary income
Profit before tax¥3.2bn2024-01-01 → 2024-06-30Cons.Income before income taxes
Profit before tax¥2.8bn2023-01-01 → 2023-06-30Cons.Income before income taxes
Net income (owners)¥2.0bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.6bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.1bn2024-01-01 → 2024-06-30Cons.Profit loss
Net income¥1.9bn2023-01-01 → 2023-06-30Cons.Profit loss
Total assets¥42.2bnat 2024-06-30Cons.Assets
Total assets¥25.4bnat 2023-12-31Cons.Assets
Total assets¥24.5bnat 2023-06-30Cons.Total assets (5-year summary)
Total liabilities¥22.6bnat 2024-06-30Cons.Liabilities
Total liabilities¥7.8bnat 2023-12-31Cons.Liabilities
Net assets / equity¥19.5bnat 2024-06-30Cons.Net assets
Net assets / equity¥17.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥17.2bnat 2023-06-30Cons.Net assets (5-year summary)
Cash and deposits¥20.9bnat 2024-06-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥20.9bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥15.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥14.4bnat 2022-12-31dCons.Cash and cash equivalents
Operating cash flow¥2.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.9bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.8bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥8.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥805m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥11.1bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.2bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥385m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥61.92024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥79.532023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.482023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥61.52024-01-01 → 2024-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥78.552023-01-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥57.652023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio46.1%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio69.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.9%at 2023-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥2m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥2.2bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥3.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥3.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥30m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2024-01-01 → 2024-06-30¥331m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2024-01-01 → 2024-06-30¥331m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2024-01-01 → 2024-06-30−¥119m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥10.9bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥10.9bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥2m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥14.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥14.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-01-01 → 2024-06-30¥2m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30¥4.5bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥1m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥1.2bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥2.9bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥2.9bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥38m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2023-01-01 → 2023-06-30¥178m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2023-01-01 → 2023-06-30¥178m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2023-01-01 → 2023-06-30−¥121m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-01-01 → 2023-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥3.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 526
ItemContextValueUnit
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1844
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember3295000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1015
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember2859000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0880
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember2309000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0711
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1579000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0486
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1340000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0412
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember947000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0292
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember933000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0287
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember648000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0200
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember507000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0156
Number of shares heldCurrentQuarterInstant20411000
Shareholding ratioCurrentQuarterInstant0.6283
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember253600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember324671
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember32467100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember17900
Number of shares issued shares voting rightsCurrentQuarterInstant32738600
Number of voting rights issued shares voting rightsCurrentQuarterInstant324671
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member253600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member253600
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0077
Number of shares held in own name treasury shares etcCurrentQuarterInstant253600
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant253600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0077
Cash and depositsPrior1YearInstant15354000000JPY
Cash and depositsCurrentQuarterInstant20855000000JPY
Accounts receivable tradePrior1YearInstant1612000000JPY
Accounts receivable tradeCurrentQuarterInstant2444000000JPY
Merchandise and finished goodsPrior1YearInstant265000000JPY
Merchandise and finished goodsCurrentQuarterInstant238000000JPY
Work in processPrior1YearInstant18000000JPY
Work in processCurrentQuarterInstant5000000JPY
Accounts receivable otherPrior1YearInstant1371000000JPY
Accounts receivable otherCurrentQuarterInstant1804000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass